Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Registrati

Quotazioni in diretta

CYTK Cytokinetics Inc

49,36

0,43 (0,88%)

Dopo l'orario di negoziazione

Ultimo aggiornamento: 22:00:10

Dati in Delay di 15 minuti

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

10/28/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

03/04/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Wendell Wierenga

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Grafico Azioni Cytokinetics (NASDAQ:CYTK)
Storico
Da Dic 2024 a Gen 2025

Clicca qui per i Grafici di Cytokinetics

Grafico Azioni Cytokinetics (NASDAQ:CYTK)
Storico
Da Gen 2024 a Gen 2025

Clicca qui per i Grafici di Cytokinetics

Notizie Cytokinetics Inc - CYTK

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Venerdì 3 Gennaio 2025 (2 ore fa) • GlobeNewswire Inc.

Cytokinetics Announces European Medicines Agency Validation of Marketing Authorization Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy
Lunedì 23 Dicembre 2024 (2 settimane fa) • GlobeNewswire Inc.

Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China
Venerdì 20 Dicembre 2024 (2 settimane fa) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 17 Dicembre 2024 (3 settimane fa) • Edgar (US Regulatory)

Form 8-K - Current report
Lunedì 16 Dicembre 2024 (3 settimane fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lunedì 16 Dicembre 2024 (3 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Giovedì 12 Dicembre 2024 (3 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 10 Dicembre 2024 (3 settimane fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Martedì 10 Dicembre 2024 (3 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Giovedì 5 Dicembre 2024 (4 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Giovedì 5 Dicembre 2024 (4 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Giovedì 5 Dicembre 2024 (4 settimane fa) • Edgar (US Regulatory)

Più Cytokinetics Inc Articoli Notizie

Intesa Sanpaolo

ST Microelectronics

Banca Monte Dei Paschi D...

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea